Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v2-EN
Language English English
Date Updated 2020-03-21 2020-02-05
Drug Identification Number 02131692 02131692
Brand name BLEOMYCIN FOR INJECTION USP BLEOMYCIN FOR INJECTION USP
Common or Proper name Bleomycin for Injection USP Bleomycin for Injection USP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients BLEOMYCIN BLEOMYCIN
Strength(s) 15UNIT 15UNIT
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRA-ARTERIAL INTRACAVITARY INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRA-ARTERIAL INTRACAVITARY INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 1 x 15IU GVL 1 x 15IU GVL
ATC code L01DC L01DC
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-02-05 2020-02-05
Estimated end date 2020-04-13
Actual end date 2020-03-20
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments